Inhibikase Therapeutics, Inc. — Institutional Ownership

Which tracked institutions hold IKT, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.

16
Funds holding
$26390884
Total value held
Buying
14 added/new · 2 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $10589768 6303433 +2997859 +90.69%
2 Blackstone Inc. $9976304 5938276 NEW BUY
3 State Street Corp $2832171 1685816 +1130967 +203.83%
4 Northern Trust Corp $1207584 718800 +396080 +122.73%
5 Bank Of America Corp /De/ $542143 322704 +276293 +595.32%
6 Bank Of New York Mellon Corp $358189 213208 +75723 +55.08%
7 Morgan Stanley $275956 164259 +84577 +106.14%
8 Goldman Sachs Group Inc $251760 149857 +64590 +75.75%
9 Wells Fargo & Company/Mn $139057 67833 +22088 +48.29%
10 Sei Investments Co $80576 47962 NEW BUY
11 Invesco Ltd. $66137 32262 -772 -2.34%
12 Barclays Plc $35865 21348 NEW BUY
13 Prudential Financial Inc $25502 15180 NEW BUY
14 Citigroup Inc $6736 3286 +2384 +264.30%
15 Royal Bank Of Canada $3000 1614 NEW BUY
16 Pnc Financial Services Group, Inc. $136 81 -20 -19.80%

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.